Comments for Center for Oncology Research & Treatment--Dallas, TX http://cancernews.wordpress.com Innovative Cancer Treatment Mon, 05 Oct 2009 23:36:07 +0000 http://wordpress.com/ hourly 1 Comment on CORT Metastatic Prostate Cancer Symposium by CORT Metastatic Prostate Cancer Symposium « Center for Oncology … | Cancer Health Wisdom http://cancernews.wordpress.com/2009/10/05/cort-metastatic-prostate-cancer-symposium/#comment-368 CORT Metastatic Prostate Cancer Symposium « Center for Oncology … | Cancer Health Wisdom Mon, 05 Oct 2009 23:36:07 +0000 http://cancernews.wordpress.com/?p=320#comment-368 [...] View post:  CORT Metastatic Prostate Cancer Symposium « Center for Oncology … [...] [...] View post:  CORT Metastatic Prostate Cancer Symposium « Center for Oncology … [...]

]]> Comment on CORT Symposium on Treatment of Her-2+ Breast Cancer by CORT Symposium on Treatment of Her-2+ Breast Cancer http://cancernews.wordpress.com/2009/10/05/cort-symposium-on-treatment-of-her-2-breast-cancer/#comment-367 CORT Symposium on Treatment of Her-2+ Breast Cancer Mon, 05 Oct 2009 15:25:44 +0000 http://cancernews.wordpress.com/?p=317#comment-367 [...] View original post here: CORT Symposium on Treatment of Her-2+ Breast Cancer [...] [...] View original post here: CORT Symposium on Treatment of Her-2+ Breast Cancer [...]

]]> Comment on STRIDE Breast Cancer Study Testing Stimuvax Cancer Vaccine Open at CORT by DennisVega http://cancernews.wordpress.com/2009/09/04/stride-breast-cancer-study-testing-stimuvax-cancer-vaccine-open-at-cort/#comment-366 DennisVega Wed, 30 Sep 2009 17:22:36 +0000 http://cancernews.wordpress.com/?p=308#comment-366 I don’t usually reply to posts but I will in this case, great info...I will add a backlink and bookmark your site. Keep up the good work! I don’t usually reply to posts but I will in this case, great info…I will add a backlink and bookmark your site. Keep up the good work!

]]> Comment on New Treatment for Her-2+ Metastatic Breast Cancer Opens at CORT by bmirtsching http://cancernews.wordpress.com/2009/09/04/new-treatment-for-her-2-metastatic-breast-cancer-opens-at-cort/#comment-365 bmirtsching Mon, 28 Sep 2009 16:59:30 +0000 http://cancernews.wordpress.com/?p=310#comment-365 This drug is only available on clinical study, in first-line use (initial therapy). There is no data about using it in other situations. Your physicians should be able to point you to trials and/or other therapies for metastatic her-2+ breast cancer. There are many other standard therapies that are not taxance (taxol, taxotere, abraxane). BCM This drug is only available on clinical study, in first-line use (initial therapy). There is no data about using it in other situations. Your physicians should be able to point you to trials and/or other therapies for metastatic her-2+ breast cancer. There are many other standard therapies that are not taxance (taxol, taxotere, abraxane).

BCM

]]> Comment on New Treatment for Her-2+ Metastatic Breast Cancer Opens at CORT by Yves Paquet http://cancernews.wordpress.com/2009/09/04/new-treatment-for-her-2-metastatic-breast-cancer-opens-at-cort/#comment-364 Yves Paquet Mon, 28 Sep 2009 15:31:33 +0000 http://cancernews.wordpress.com/?p=310#comment-364 Hi, mi wife is fighting a old metastatic breast cancer since 2000. She received a lot of chemo(200), taxotere,herceptin and now, Abraxanne. With Abraxanne, the cancer did not progres. She tries to come back to taxotere and cancer grow up. Is neratinib could be use with abraxanne ? I suppose that if it's possible teh result could be very good. We are Canadian (québec) and research are always in late here. I know she won't abel to receive an other 200 chemo(side effects) and i'm looking to find other solutions. The question is : could you help us ? Thanks Yves Paquet Hi, mi wife is fighting a old metastatic breast cancer since 2000.
She received a lot of chemo(200), taxotere,herceptin and now, Abraxanne.
With Abraxanne, the cancer did not progres. She tries to come back to taxotere and cancer grow up.
Is neratinib could be use with abraxanne ?
I suppose that if it’s possible teh result could be very good.
We are Canadian (québec) and research are always in late here.
I know she won’t abel to receive an other 200 chemo(side effects) and i’m looking to find other solutions.

The question is : could you help us ?

Thanks

Yves Paquet

]]> Comment on ABCSG-12: Zoledronic Acid (Zometa) Reduces Recurrence of Early Breast Cancer by bmirtsching http://cancernews.wordpress.com/2008/11/05/abcsg-12-zoledronic-acid-zometa-reduces-recurrence-of-early-breast-cancer/#comment-363 bmirtsching Thu, 17 Sep 2009 12:39:02 +0000 http://cancernews.wordpress.com/?p=117#comment-363 No, there was no critieria for low bone density to enter the study. The study was reported in the New England Journal of Medicine on February 12, 2009. That report did not report the changes in bone density in the treatment groups. It did note in the discussion that zoledronic acid effectively prevented bone loss in patients receiving adjuvant therapy with aromatase inhibitors. The detailed information on the bone effects of zoledronic acid in the premenopausal group of women in this study will hopefully be reported separately. No, there was no critieria for low bone density to enter the study. The study was reported in the New England Journal of Medicine on February 12, 2009. That report did not report the changes in bone density in the treatment groups. It did note in the discussion that zoledronic acid effectively prevented bone loss in patients receiving adjuvant therapy with aromatase inhibitors. The detailed information on the bone effects of zoledronic acid in the premenopausal group of women in this study will hopefully be reported separately.

]]> Comment on Bisphosphonate (Zoledronic Acid=Zometa) Improves Adjuvant Endocrine Therapy for Pre-menopausal Breast Cancer Patients; Ongoing CORT Study Assesses Bisphosphonates in Adjuvant Therapy in Broader Groups of Patients by shylove http://cancernews.wordpress.com/2008/06/06/bisphosphonate-zoledronic-acidzometa-improves-adjuvant-endocrine-therapy-for-pre-menopausal-breast-cancer-patients-ongoing-cort-study-assesses-bisphosphonates-in-adjuvant-therapy-in-broader-groups/#comment-357 shylove Mon, 07 Sep 2009 04:15:08 +0000 http://cancernews.wordpress.com/?p=50#comment-357 Nice to read this, Thank for your sharing. Very helpfull for me :) Nice to read this, Thank for your sharing. Very helpfull for me :)

]]> Comment on New Treatment for Her-2+ Metastatic Breast Cancer Opens at CORT by New Treatment for Her-2+ Metastatic Breast Cancer Opens at CORT … http://cancernews.wordpress.com/2009/09/04/new-treatment-for-her-2-metastatic-breast-cancer-opens-at-cort/#comment-355 New Treatment for Her-2+ Metastatic Breast Cancer Opens at CORT … Sat, 05 Sep 2009 21:19:00 +0000 http://cancernews.wordpress.com/?p=310#comment-355 [...] Go here to read the rest:  New Treatment for Her-2+ Metastatic Breast Cancer Opens at CORT … [...] [...] Go here to read the rest:  New Treatment for Her-2+ Metastatic Breast Cancer Opens at CORT … [...]

]]> Comment on Study Tests Extension of Anti-Her-2 Therapy Beyond Herceptin for Early Stage Breast Cancer Patients by bmirtsching http://cancernews.wordpress.com/2009/08/05/study-tests-extension-of-anti-her-2-therapy-beyond-herceptin-for-early-stage-breast-cancer-patients/#comment-354 bmirtsching Fri, 04 Sep 2009 16:37:29 +0000 http://cancernews.wordpress.com/?p=300#comment-354 The trial requires completion of 12 months of Herceptin. In reviewing further, if a patient has not been able to complete Herceptin, a minimum of 8 weekly doses, or three doses of every-three-week dosing are minimum requirements. The trial requires completion of 12 months of Herceptin. In reviewing further, if a patient has not been able to complete Herceptin, a minimum of 8 weekly doses, or three doses of every-three-week dosing are minimum requirements.

]]> Comment on Study Tests Extension of Anti-Her-2 Therapy Beyond Herceptin for Early Stage Breast Cancer Patients by Lori Worbington http://cancernews.wordpress.com/2009/08/05/study-tests-extension-of-anti-her-2-therapy-beyond-herceptin-for-early-stage-breast-cancer-patients/#comment-353 Lori Worbington Fri, 04 Sep 2009 01:01:03 +0000 http://cancernews.wordpress.com/?p=300#comment-353 I am wondering if someone had 6 months of Herceptin verses 12, within 2 years, would they still be eligible for the clinical trial? I am wondering if someone had 6 months of Herceptin verses 12, within 2 years, would they still be eligible for the clinical trial?

]]>